Concepedia

Mohammed Nakodi Yisa

MN

Statistics

Publications

2

Citations

106

H-Index

2

Active since

2022

Affiliations

National Center for Immunization and Respiratory Diseases(Current)

Centers for Disease Control and Prevention

Micron Biomedical (United States)

MRC Unit the Gambia

Mohammed Nakodi Yisa is an author at National Center for Immunization and Respiratory Diseases specializing in microneedle-based delivery, pediatric immunization, and infectious diseases.

ORCID

Publications per year

2022–2024

2

Publications

2

A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial

Ikechukwu Adigweme, Mohammed Nakodi Yisa, Michael Ooko et al. · The Lancet · 2024 · 81 citations · Full text

, , +17

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]

Ikechukwu Adigweme, Edem Akpalu, Mohammed Nakodi Yisa et al. · Trials · 2022 · 25 citations · Full text

, , +17

1–2 of 2